PCQUELL Stock Latest News
Private CompaniesQuell Therapeutics Advances CHILL Trial for Autoimmune Cell Therapy4M agoQUELL
Private CompaniesQuell Therapeutics Expands CHILL Study Sites for QEL-005 Autoimmune Trial4M agoQUELL
Private CompaniesQuell Therapeutics Highlights Progress on QEL-005 and CHILL Autoimmune Study5M agoQUELL
Private CompaniesQuell Therapeutics Builds Momentum in CHILL Autoimmune Trial Around EULAR 20265M agoQUELL
Private CompaniesQuell Therapeutics Highlights Momentum in Autoimmune CHILL Program Around EULAR Meeting5M agoQUELLPrivate CompaniesQuell Therapeutics Highlights Stakeholder Engagement Around CHILL Autoimmune Program5M agoQUELL
Private CompaniesQuell Therapeutics Accelerates CHILL Trial and Showcases QEL-005 at EULAR 20265M agoQUELL
Private CompaniesQuell Therapeutics Highlights Progress in QEL-005 and CHILL Autoimmune Trial5M agoQUELL
Private CompaniesQuell Therapeutics Showcases Accelerated Start-Up for CHILL CAR-Treg Clinical Study5M agoQUELLPrivate CompaniesQuell Therapeutics’ CHILL Trial Highlighted for Accelerated U.K. Activation5M agoQUELL
Private CompaniesQuell Therapeutics Highlights Accelerated Start-Up of CHILL CAR-Treg Clinical Study5M agoQUELL
Private CompaniesQuell Therapeutics – Weekly Recap6M agoQUELL
Private CompaniesQuell Therapeutics Highlights CHILL Trial Progress and U.K. Cell Therapy Ecosystem6M agoQUELL
Private CompaniesQuell Therapeutics Highlights CHILL Trial Progress and U.K. Cell Therapy Ecosystem6M agoQUELL
Private CompaniesQuell Therapeutics Expands CHILL Clinical Trial Sites for QEL‑005 Autoimmune Therapy6M agoQUELLPrivate CompaniesQuell Therapeutics Advances Multinational CHILL Trial for CAR-Treg Therapy6M agoQUELL



